MERILOG Trademark
MERILOG is a USPTO trademark filed by Sanofi. Status: Pending.
Prosecution Summary
Trademark Summary
MERILOG is a stylized word mark with a geometric shape above the "M", covering pharmaceuticals for diabetes prevention and treatment including insulin (class 005), discount program administration and diabetes awareness promotion (class 035), diabetes training and educational conferences plus healthcare podcasts (class 041), and medical information plus support services for diabetes and related disorders (class 044). Owned by French corporation Sanofi, the application is on the Principal Register under intent-to-use basis. Notice of Allowance was issued on February 24, 2026, requiring a Statement of Use or extension within six months; all classes remain active with no notable issues.
Recent Activity
Filed March 14, 2025, the application faced a non
Trademark Facts
| Mark | MERILOG |
|---|---|
| Serial Number | 99084375 |
| Status | Pending |
| Filing Date | 2025-03-14 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 035 (Advertising & Business), 041 (Education & Entertainment), 044 (Medical Services) |
| Owner | Sanofi |
| Attorney of Record | Alexandra Kochian |
| Prosecution Events | 21 |
| Latest Event | NOAM on 2026-02-24 |
Goods & Services
Providing training in the field of diabetes and injecting insulin; Publication of articles and scientific journals; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of healthcare and medicine for health care providers, care givers, health care insurers, payers in the healthcare field, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases; Entertainment services, namely, providing podcasts in the field of healthcare and medicine; Educational services, namely, conducting conferences, training, seminars, congresses, presentations, and workshops in the field of healthcare and medicine and distribution of educational materials in connection therewith, all the foregoing distributed across multiple forms of transmission media including online via the internet and via social network platforms; Pharmaceutical preparations for human use; Insulin; Administration of a program for enabling participants to obtain discounts on products and services; Administration of a discount program for enabling participants to obtain discounts on goods and services through use of a discount membership card; Promoting public awareness of medications and treatments for diabetes; Providing business information in the field of patient relationship management services for the purpose of assisting prospective patients regarding the treatment of disease via a web site; Providing business information in the field of business administration of patient reimbursement programs regarding medical treatment payment plan options for patients undergoing treatment of disease; Providing medical information in the field of diabetes; Providing medical information; Medical services; Medical services in the field of diabetes, autoimmune diseases and disorders, and related diseases and disorders, namely, providing medical and psychological support for healthcare professionals, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases and disorders; Providing medical information in the field of prevention and treatment of diabetes, autoimmune diseases and disorders, and diseases and disorders related to diabetes; Providing medical information in the field of diabetes, treatment of the disease, burden of the disease, and pathophysiology of the autoimmune nature of the disease via a website; Providing medical information in the field of diabetes, autoimmune diseases, and related diseases and disorders, and on the prevention and early diagnosis of asymptomatic Type 1 diabetes, to health care providers; Providing medical information in the field of diabetes and autoimmune diseases to patients, health care professionals, and caregivers via electronic media, via the Internet, and via social networks; Providing medical information in the field of life threatening disorders, namely, providing educational information to caregivers and patients in the field of personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, treatment management, all of the aforesaid provided via website or telephone, non-downloadable webinars, and printed material distributed in connection therewith; Providing educational information about healthcare